Until now, there has been no successful treatment for a relatively rare skin condition called vitiligo. For reasons that remain mysterious, some people develop depigmentation of portions of their skin. It can occur on hands, feet and face. Dermatologists have been at a loss to reverse the loss of pigment, although ultraviolet therapy can sometimes be partially helpful.
Now a pilot study suggests that a new drug mimicking melanocyte-stimulating hormone speeds repigmentation with UV B light exposure. Melanocytes are the cells that contain pigment.
The drug, afamelanotide, produced natural-looking pigment over 75% of previously depigmented skin. The darker the skin, the more noticeable the repigmentation. Side effects included nausea, fatigue, headache and dizziness. This tiny study offers proof of concept for a drug that will require more extensive testing.
[JAMA Dermatology, Jan. 2013]

Join Over 56,000 Subscribers at The People's Pharmacy

Each week we send two free email newsletters with breaking health news, prescription drug information, home remedies and a preview of our award-winning radio show. Join our mailing list and get the information you need to make confident choices about your health.

  1. James

    @alan: If it comes and goes, have you been evaluated for tinea versicolor? It can look superficially similar to vitiligo but it is caused by yeast and would more easily appear and disappear. The two can even be confused by physicians. Some people reportedly find selenium shampoo to be helpful in controlling tinea versicolor.

  2. alan

    I get what SEEMS to be this condition off and on. same stuff? only happens on my hands, tho.

What Do You Think?

Share your thoughts with others, but be mindful of protecting your own and others' privacy. Not all comments will be posted. Advice from web visitors is not a substitute for medical attention. Do not stop any medicine without checking with the prescriber. In posting a comment, you agree to our commenting policy and website terms and conditions.